Src family kinases are involved in the differential signaling from two splice forms of C-kit

被引:77
作者
Voytyuk, O
Lennartsson, J
Mogi, A
Caruana, G
Courtneidge, S
Ashman, LK
Rönnstrand, L
机构
[1] Ludwig Inst Canc Res, Ctr Biomed, SE-75124 Uppsala, Sweden
[2] Monash Univ, Dept Anat & Cell Biol, Clayton, Vic 3800, Australia
[3] Van Andel Inst, Grand Rapids, MI 49503 USA
[4] Univ Newcastle, Sch Biomed Sci, Callaghan, NSW 2308, Australia
关键词
D O I
10.1074/jbc.M211726200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In both mice and humans alternate splicing results in isoforms of c-Kit characterized by the presence or the absence of a tetrapeptide sequence, GNNK, in the juxtamembrane region of the extracellular domain. Dramatic differences in the kinetics and magnitude of activation of the intrinsic tyrosine kinase activity of c-Kit between the GNNK- and GNNK+ isoforms has previously been shown. Here we report the analysis of downstream targets of receptor signaling, which revealed that the signaling was differentially regulated in the two splice forms. The kinetics of phosphorylation of Shc, previously demonstrated to be phosphorylated by Src downstream of c-Kit, was stronger and more rapid in the GNNK- form, whereas it showed slower kinetics in the GNNK+ form. Inhibition of Src family kinases with the specific Src, family kinase inhibitor SU6656 altered the kinetics of activation of the GNNK- form of c-Kit so that it resembled that of the GNNK+ form. In cells expressing the GNNK- form, SCF was rapidly degraded, whereas in cells expressing the GNNK+ form only showed a very slow rate of degradation of SCF. In the GNNK+ form the Src inhibitor SU6656 only had a weak effect on degradation, whereas in the GNNK- form it dramatically inhibited degradation. In summary, the two splice forms show, despite only a four-amino acid sequence difference, remarkable differences in their signaling capabilities.
引用
收藏
页码:9159 / 9166
页数:8
相关论文
共 39 条
[1]   The biology of stem cell factor and its receptor C-kit [J].
Ashman, LK .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1999, 31 (10) :1037-1051
[2]   Rotational coupling of the transmembrane and kinase domains of the Neu receptor tyrosine kinase [J].
Bell, CA ;
Tynan, JA ;
Hart, KC ;
Meyer, AN ;
Robertson, SC ;
Donoghue, DJ .
MOLECULAR BIOLOGY OF THE CELL, 2000, 11 (10) :3589-3599
[3]   c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function [J].
Biscardi, JS ;
Maa, MC ;
Tice, DA ;
Cox, ME ;
Leu, TH ;
Parsons, SJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (12) :8335-8343
[4]   SU6656, a selective Src family kinase inhibitor, used to probe growth factor signaling [J].
Blake, RA ;
Broome, MA ;
Liu, XD ;
Wu, JM ;
Gishizky, M ;
Sun, L ;
Courtneidge, SA .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (23) :9018-9027
[5]   ACTIVATION OF THE HUMAN C-KIT PRODUCT BY LIGAND-INDUCED DIMERIZATION MEDIATES CIRCULAR ACTIN REORGANIZATION AND CHEMOTAXIS [J].
BLUMEJENSEN, P ;
CLAESSONWELSH, L ;
SIEGBAHN, A ;
ZSEBO, KM ;
WESTERMARK, B ;
HELDIN, CH .
EMBO JOURNAL, 1991, 10 (13) :4121-4128
[6]   INCREASED KIT/SCF RECEPTOR-INDUCED MITOGENICITY BUT ABOLISHED CELL MOTILITY AFTER INHIBITION OF PROTEIN-KINASE-C [J].
BLUMEJENSEN, P ;
SIEGBAHN, A ;
STABEL, S ;
HELDIN, CH ;
RONNSTRAND, L .
EMBO JOURNAL, 1993, 12 (11) :4199-4209
[7]  
Bondzi C, 2000, CELL GROWTH DIFFER, V11, P305
[8]  
Broudy VC, 1999, BLOOD, V94, P1979
[9]   Isoforms of c-KIT differ in activation of signalling pathways and transformation of NIH3T3 fibroblasts [J].
Caruana, G ;
Cambareri, AC ;
Ashman, LK .
ONCOGENE, 1999, 18 (40) :5573-5581
[10]   THE PROTO-ONCOGENE C-KIT ENCODING A TRANSMEMBRANE TYROSINE KINASE RECEPTOR MAPS TO THE MOUSE W-LOCUS [J].
CHABOT, B ;
STEPHENSON, DA ;
CHAPMAN, VM ;
BESMER, P ;
BERNSTEIN, A .
NATURE, 1988, 335 (6185) :88-89